<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Baumgartner A</submitter><funding>Swiss National Science Foundation</funding><funding>Forschungsrat of the Kantonsspital Aarau</funding><pagination>1843-1850</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7547398</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>40(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>In polymorbid patients with bronchopulmonary infection, malnutrition is an independent risk factor for mortality. There is a lack of interventional data investigating whether providing nutritional support during the hospital stay in patients at risk for malnutrition presenting with lower respiratory tract infection lowers mortality.&lt;h4>Methods&lt;/h4>For this secondary analysis of a randomized clinical trial (EFFORT), we analyzed data of a subgroup of patients with confirmed lower respiratory tract infection from an initial cohort of 2028 patients. Patients at nutritional risk (Nutritional Risk Screening [NRS] score ≥3 points) were randomized to receive protocol-guided individualized nutritional support to reach protein and energy goals (intervention group) or standard hospital food (control group). The primary endpoint of this analysis was all-cause 30-day mortality.&lt;h4>Results&lt;/h4>We included 378 of 2028 EFFORT patients (mean age 74.4 years, 24% with COPD) into this analysis. Compared to usual care hospital nutrition, individualized nutritional support to reach caloric and protein goals showed a similar beneficial effect of on the risk of mortality in the subgroup of respiratory tract infection patients as compared to the main EFFORT trial (odds ratio 0.47 [95%CI 0.17 to 1.27, p = 0.136] vs 0.65 [95%CI 0.47 to 0.91, p = 0.011]) with no evidence of a subgroup effect (p for interaction 0.859). Effects were also similar among different subgroups based on etiology and type of respiratory tract infection and for other secondary endpoints.&lt;h4>Conclusion&lt;/h4>This subgroup analysis from a large nutrition support trial suggests that patients at nutritional risk as assessed by NRS 2002 presenting with bronchopulmonary infection to the hospital likely have a mortality benefit from individualized inhospital nutritional support. The small sample size and limited statistical power calls for larger nutritional studies focusing on this highly vulnerable patient population.&lt;h4>Clinical trial registration&lt;/h4>Registered under ClinicalTrials.gov Identifier no. NCT02517476.</pubmed_abstract><journal>Clinical nutrition (Edinburgh, Scotland)</journal><pubmed_title>Effect of nutritional support in patients with lower respiratory tract infection: Secondary analysis of a randomized clinical trial.</pubmed_title><pmcid>PMC7547398</pmcid><funding_grant_id>1410.000.058</funding_grant_id><funding_grant_id>1410.000.044</funding_grant_id><pubmed_authors>Hersberger L</pubmed_authors><pubmed_authors>Donze J</pubmed_authors><pubmed_authors>Pavlicek V</pubmed_authors><pubmed_authors>Rutishauser J</pubmed_authors><pubmed_authors>Brandle M</pubmed_authors><pubmed_authors>Bargetzi L</pubmed_authors><pubmed_authors>Cantone J</pubmed_authors><pubmed_authors>Schuetz P</pubmed_authors><pubmed_authors>Aujesky D</pubmed_authors><pubmed_authors>Bargetzi A</pubmed_authors><pubmed_authors>Gomes F</pubmed_authors><pubmed_authors>Hasenboehler F</pubmed_authors><pubmed_authors>Thomann R</pubmed_authors><pubmed_authors>Kaegi-Braun N</pubmed_authors><pubmed_authors>Mueller B</pubmed_authors><pubmed_authors>Hoess C</pubmed_authors><pubmed_authors>Tribolet P</pubmed_authors><pubmed_authors>Sigrist S</pubmed_authors><pubmed_authors>Henzen C</pubmed_authors><pubmed_authors>Bilz S</pubmed_authors><pubmed_authors>Baumgartner A</pubmed_authors><pubmed_authors>Stanga Z</pubmed_authors><pubmed_authors>Rodondi N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of nutritional support in patients with lower respiratory tract infection: Secondary analysis of a randomized clinical trial.</name><description>&lt;h4>Background&lt;/h4>In polymorbid patients with bronchopulmonary infection, malnutrition is an independent risk factor for mortality. There is a lack of interventional data investigating whether providing nutritional support during the hospital stay in patients at risk for malnutrition presenting with lower respiratory tract infection lowers mortality.&lt;h4>Methods&lt;/h4>For this secondary analysis of a randomized clinical trial (EFFORT), we analyzed data of a subgroup of patients with confirmed lower respiratory tract infection from an initial cohort of 2028 patients. Patients at nutritional risk (Nutritional Risk Screening [NRS] score ≥3 points) were randomized to receive protocol-guided individualized nutritional support to reach protein and energy goals (intervention group) or standard hospital food (control group). The primary endpoint of this analysis was all-cause 30-day mortality.&lt;h4>Results&lt;/h4>We included 378 of 2028 EFFORT patients (mean age 74.4 years, 24% with COPD) into this analysis. Compared to usual care hospital nutrition, individualized nutritional support to reach caloric and protein goals showed a similar beneficial effect of on the risk of mortality in the subgroup of respiratory tract infection patients as compared to the main EFFORT trial (odds ratio 0.47 [95%CI 0.17 to 1.27, p = 0.136] vs 0.65 [95%CI 0.47 to 0.91, p = 0.011]) with no evidence of a subgroup effect (p for interaction 0.859). Effects were also similar among different subgroups based on etiology and type of respiratory tract infection and for other secondary endpoints.&lt;h4>Conclusion&lt;/h4>This subgroup analysis from a large nutrition support trial suggests that patients at nutritional risk as assessed by NRS 2002 presenting with bronchopulmonary infection to the hospital likely have a mortality benefit from individualized inhospital nutritional support. The small sample size and limited statistical power calls for larger nutritional studies focusing on this highly vulnerable patient population.&lt;h4>Clinical trial registration&lt;/h4>Registered under ClinicalTrials.gov Identifier no. NCT02517476.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2024-10-15T06:59:32.754Z</modification><creation>2020-10-29T15:56:59Z</creation></dates><accession>S-EPMC7547398</accession><cross_references><pubmed>33081983</pubmed><doi>10.1016/j.clnu.2020.10.009</doi></cross_references></HashMap>